A Sodium 1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylamino methanesulfonate DMF (Drug Master File) is a document detailing the whole manufacturing process of Sodium 1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylamino methanesulfonate active pharmaceutical ingredient (API) in detail. Different forms of Sodium 1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylamino methanesulfonate DMFs exist exist since differing nations have different regulations, such as Sodium 1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylamino methanesulfonate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sodium 1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylamino methanesulfonate DMF submitted to regulatory agencies in the US is known as a USDMF. Sodium 1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylamino methanesulfonate USDMF includes data on Sodium 1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylamino methanesulfonate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sodium 1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylamino methanesulfonate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sodium 1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylamino methanesulfonate suppliers with USDMF on PharmaCompass.